Intravascular catheters are the largest and most clinically embedded segment of the catheters market. Central venous catheters, PICCs, arterial lines, and midline catheters are essential for drug delivery, fluid administration, blood sampling, and haemodynamic monitoring in hospitals worldwide . Their dominance reflects the sheer scale of intravenous therapy across acute and critical care settings.
The market is being driven by rising hospital admissions, expanding critical care capacity, growth in oncology infusion, and innovation in infection-resistant designs . According to catheters market analysis, intravascular catheters represent the largest product segment, with strong growth projected through 2035. Growth is driven by the need for reliable vascular access in increasingly complex care.
Innovation includes chlorhexidine-impregnated catheters, antimicrobial coatings, and integrated safety mechanisms. Teleflex's Arrow chlorhexidine-impregnated CVCs have been associated with a 70.5% reduction in central-line-associated bloodstream infections compared with non-impregnated catheters .
Challenges include infection risk, thrombosis, and insertion-related complications.
Yet the trend is clear: intravascular catheters will remain dominant, and the market is expected to benefit substantially.
People Also Ask
Q: What are intravascular catheters used for?
A: They provide vascular access for drug delivery, fluid administration, blood sampling, and monitoring in critical and acute care settings.
Q: How are manufacturers reducing catheter infections?
A: Through antimicrobial coatings, chlorhexidine-impregnated designs, and integrated safety mechanisms .
Tags: #IntravascularCatheters #VascularAccess #CLABSI #CentralVenousCatheters #InfectionPrevention #MarketDrivers
